Revenue
No reported data
Genenta Science S.p.A. (GNTA)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Research & development | €2.7M | €4.8M | €6.5M | €5.3M | €3.4M | €4.7M | €3.7M |
| Operating expenses | €6.6M | €9.8M | €11.7M | €11.0M | €5.7M | €5.6M | €4.6M |
| Operating income | −€6.6M | −€9.8M | −€11.7M | −€11.0M | −€5.7M | −€5.6M | −€4.6M |
| EBITDAderived | −€6.6M | −€9.7M | −€11.7M | −€11.0M | −€5.7M | −€5.6M | — |
| Net income | −€6.5M | −€8.9M | −€11.6M | −€8.5M | −€5.5M | −€5.6M | −€4.6M |
| Basic EPSper diluted share | — | — | -€0.64 | -€0.47 | -€0.37 | — | — |
| Diluted EPSper diluted share | -€0.33 | -€0.49 | -€0.64 | -€0.47 | -€0.37 | — | — |